Express Pharma

Sputnik V vaccine shows 92 per cent efficacy in ongoing phase III trials in Russia

The confirmation is based on the first interim data from the double-blind, randomized, placebo-controlled Phase III clinical trials in Russia involving 40,000 volunteers